Events

Dr Jürgen Brem, Oxford University, will speak on day two of the 4^th annual AMR Conference (25 August, 11:15-12:15 CET) in a session entitled ENABLE: A public-private partnership for antibiotic development. During his presentation, Jürgen will touch on his collaborative work within the framework of two IMI projects, ELF and ENABLE, to develop a novel therapy to tackle antibiotic resistance. The Conference takes place over a week from 24-28 August and will be held online.

Laurine Brouck, PhD student of Dr Achim Schnaufer from the University of Edinburgh, will present her ELF related work at the Trypanosomiasis and Leishmaniasis Seminar, hosted by the British Society of Parasitology in Granada, Spain on 8-12 March.

On November 13, the European Lead Factory held its annual stakeholder meeting at Merck in Darmstadt, Germany. The meeting brought together the consortium partners, programme owners, and numerous relevant organizations in the drug discovery domain. Through interactive presentations, updates were provided on the progress of the ELF initiative in general, on specific drug discovery programs in more detail and on opportunities for new collaborations. We invite you to foster existing relationships and build new collaborations. Read the full report. 

Dr. Dimitrios Tzalis, ELF Head of Chemistry and CEO of Taros Chemicals will give a presentation at 5th Annual Drug Discovery USA Congress, 2-3 October 2018, San Diego, USA.